APA (7th ed.) Citation

N, O., H, M., J, K., T, K., Y, A., T, M., . . . A, T. (2026). Impact of Acute Graft-Versus-Host Disease and Delayed Hematopoietic Recovery on the Incidence and Clinical Burden of Late Cytomegalovirus Reactivation and Disease After Letermovir Prophylaxis During the First 100 Days After Cord Blood Transplantation. Transplantation and cellular therapy. https://doi.org/10.1016/j.jtct.2026.06.020

Chicago Style (17th ed.) Citation

N, Okada, et al. "Impact of Acute Graft-Versus-Host Disease and Delayed Hematopoietic Recovery on the Incidence and Clinical Burden of Late Cytomegalovirus Reactivation and Disease After Letermovir Prophylaxis During the First 100 Days After Cord Blood Transplantation." Transplantation and Cellular Therapy 2026. https://doi.org/10.1016/j.jtct.2026.06.020.

MLA (9th ed.) Citation

N, Okada, et al. "Impact of Acute Graft-Versus-Host Disease and Delayed Hematopoietic Recovery on the Incidence and Clinical Burden of Late Cytomegalovirus Reactivation and Disease After Letermovir Prophylaxis During the First 100 Days After Cord Blood Transplantation." Transplantation and Cellular Therapy, 2026, https://doi.org/10.1016/j.jtct.2026.06.020.